HU Yong-fang

875 total citations
24 papers, 662 citations indexed

About

HU Yong-fang is a scholar working on Pediatrics, Perinatology and Child Health, Transplantation and Molecular Biology. According to data from OpenAlex, HU Yong-fang has authored 24 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Transplantation and 5 papers in Molecular Biology. Recurrent topics in HU Yong-fang's work include Renal Transplantation Outcomes and Treatments (7 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pharmacogenetics and Drug Metabolism (4 papers). HU Yong-fang is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pharmacogenetics and Drug Metabolism (4 papers). HU Yong-fang collaborates with scholars based in China, United States and Australia. HU Yong-fang's co-authors include Huilin Tang, Suodi Zhai, Yao Yao, Hong‐Guang Xie, Yan Li, Dan Wang, Jun He, Caihong Ma, Hong‐Guang Xie and Tamara Hunter and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

HU Yong-fang

21 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HU Yong-fang China 10 203 191 137 130 127 24 662
Karl Brendel France 11 291 1.4× 56 0.3× 110 0.8× 90 0.7× 57 0.4× 19 1.1k
Christian Laveille France 14 176 0.9× 38 0.2× 102 0.7× 117 0.9× 47 0.4× 33 1.0k
Stanley M. Cohen United States 17 56 0.3× 50 0.3× 148 1.1× 350 2.7× 54 0.4× 66 1.5k
May Fakhoury France 19 577 2.8× 304 1.6× 132 1.0× 93 0.7× 256 2.0× 28 1.2k
Julie Borland United States 26 304 1.5× 25 0.1× 97 0.7× 249 1.9× 67 0.5× 52 2.0k
Kelly A. Birdwell United States 14 350 1.7× 484 2.5× 293 2.1× 211 1.6× 85 0.7× 34 1.2k
Roshan Shrestha United States 22 74 0.4× 156 0.8× 272 2.0× 975 7.5× 224 1.8× 61 2.0k
Azemi Barama Canada 14 190 0.9× 351 1.8× 166 1.2× 126 1.0× 51 0.4× 28 672
Vandana Khungar United States 15 28 0.1× 52 0.3× 25 0.2× 213 1.6× 72 0.6× 35 889
Richard Gilroy United States 22 92 0.5× 128 0.7× 23 0.2× 670 5.2× 148 1.2× 65 1.9k

Countries citing papers authored by HU Yong-fang

Since Specialization
Citations

This map shows the geographic impact of HU Yong-fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HU Yong-fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HU Yong-fang more than expected).

Fields of papers citing papers by HU Yong-fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HU Yong-fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HU Yong-fang. The network helps show where HU Yong-fang may publish in the future.

Co-authorship network of co-authors of HU Yong-fang

This figure shows the co-authorship network connecting the top 25 collaborators of HU Yong-fang. A scholar is included among the top collaborators of HU Yong-fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HU Yong-fang. HU Yong-fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Jing, et al.. (2025). Rocuronium-Induced Rhabdomyolysis: A Case Report and Literature Review. Cureus. 17(10). e94426–e94426.
2.
Zhang, Zhen‐Yu, et al.. (2024). Relevance of perioperative fluid dynamics in liver transplantation to acute kidney injury and patient outcomes: a cross-sectional survey. Journal of Pharmaceutical Policy and Practice. 18(1). 2438225–2438225. 1 indexed citations
3.
Zhang, Weiwei, et al.. (2021). Utilization of neurosurgical perioperative antimicrobial prophylaxis in a Chinese teaching hospital. International Journal of Clinical Pharmacy. 43(5). 1191–1197. 1 indexed citations
4.
Wang, Fan, Yu Li, Shengling Li, et al.. (2020). Effects of kangaroo mother care on anxiety and parenting stress in premature mothers. Zhonghua xingwei yixue yu naokexue zazhi. 29(1). 74–78. 2 indexed citations
5.
Tang, Jie, Jing Xu, Rong Liu, et al.. (2019). Incorporation of Gene‐Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant Recipients. The Journal of Clinical Pharmacology. 59(6). 890–899. 7 indexed citations
6.
Tang, Jie, Rong Liu, Yueli Zhang, et al.. (2017). Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients. Scientific Reports. 7(1). 42192–42192. 117 indexed citations
7.
Liu, Mouze, Yueli Zhang, HU Yong-fang, et al.. (2017). IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. Acta Pharmacologica Sinica. 38(3). 415–423. 24 indexed citations
8.
Zhao, Rongsheng, Suodi Zhai, Li Yang, et al.. (2014). Comparison of U.S. and Chinese pharmacy education programs. American Journal of Health-System Pharmacy. 71(5). 425–429. 5 indexed citations
9.
10.
Penm, Jonathan, Yan Li, Suodi Zhai, et al.. (2013). The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China’s current healthcare reform. Health Policy and Planning. 29(7). 849–872. 32 indexed citations
11.
Li, Hong-Liang, Xi Zhu, Gaiqi Yao, et al.. (2012). [Pharmacokinetics of meropenem administered with prolonged infusion time in patients receiving continuous veno-venous hemofiltration].. PubMed. 24(3). 145–8. 2 indexed citations
12.
Tang, Huilin, et al.. (2012). Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews. CD008605–CD008605. 76 indexed citations
13.
Tang, Huilin, Hong‐Guang Xie, Yao Yao, & HU Yong-fang. (2011). Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressers. Pharmacogenetics and Genomics. 21(11). 713–720. 62 indexed citations
14.
Yao, Yao, Caihong Ma, Huilin Tang, & HU Yong-fang. (2011). Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis. Molecular Genetics and Metabolism. 103(4). 388–393. 61 indexed citations
15.
Yong-fang, HU, et al.. (2010). Influence of VKORC1-1639G>A Genetic Polymorphism on Mean Daily Dose of Warfarin in Asian Populations:A Systematic Review and Meta-analysis. Zhongguo yaofang.
16.
Tang, Huilin, Lulin Ma, Hong‐Guang Xie, Ting Zhang, & HU Yong-fang. (2010). Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysis. Pharmacogenetics and Genomics. 20(9). 525–531. 29 indexed citations
17.
Wang, Dan, Xiaoyan Ke, Jing Wang, Xu Fang, & HU Yong-fang. (2007). [Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia].. PubMed. 87(20). 1384–8. 2 indexed citations
18.
Yong-fang, HU, Wen Qiu, Zhaoqian Liu, et al.. (2006). EFFECTS OF GENETIC POLYMORPHISMS OFCYP3A4,CYP3A5ANDMDR1ON CYCLOSPORINE PHARMACOKINETICS AFTER RENAL TRANSPLANTATION. Clinical and Experimental Pharmacology and Physiology. 33(11). 1093–1098. 72 indexed citations
19.
Yong-fang, HU, Jun He, Guo‐Lin Chen, et al.. (2005). CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population. Clinica Chimica Acta. 353(1-2). 187–192. 83 indexed citations
20.
Liu, Zhongqi, Yongquan Tian, Cong Peng, et al.. (2005). Expression of NASG gene and its role in human nasopharyngeal homogenous tissue cells.. PubMed. 118(13). 1076–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl Brendel Breakdown of academic impact, for papers by Christian Laveille Breakdown of academic impact, for papers by Stanley M. Cohen Breakdown of academic impact, for papers by May Fakhoury Breakdown of academic impact, for papers by Julie Borland Breakdown of academic impact, for papers by Kelly A. Birdwell Breakdown of academic impact, for papers by Roshan Shrestha Breakdown of academic impact, for papers by Azemi Barama Breakdown of academic impact, for papers by Vandana Khungar Breakdown of academic impact, for papers by Richard Gilroy
Rankless by CCL
2026